Sumatriptan is
## **Core Concept**
Sumatriptan is a medication used for the treatment of migraine headaches. It belongs to a class of drugs known as **triptans** or **serotonin receptor agonists**. These drugs work by selectively stimulating certain serotonin receptors in the brain.
## **Why the Correct Answer is Right**
The correct answer, **serotonin receptor agonist**, is right because sumatriptan exerts its therapeutic effect by selectively agonizing the **5-HT1B and 5-HT1D receptors**. This selective agonism leads to vasoconstriction of intracranial blood vessels and inhibition of pro-inflammatory neuropeptide release, which are key steps in the pathophysiology of migraine headaches. By activating these receptors, sumatriptan helps alleviate the pain and other symptoms associated with migraines.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because sumatriptan does not primarily work as an **anticholinergic agent**. Anticholinergic agents block the action of acetylcholine at muscarinic receptors, which is not the mechanism by which sumatriptan exerts its effects.
- **Option B:** This option is incorrect because sumatriptan is not classified as a **beta-blocker**. Beta-blockers are used in the treatment of hypertension, angina, and certain other conditions by blocking the effects of epinephrine (adrenaline) and norepinephrine (noradrenaline) on beta receptors, which is unrelated to sumatriptan's mechanism of action.
- **Option C:** This option might seem plausible because sumatriptan does have effects that could indirectly relate to **vasoconstriction**, but it is not specifically a **vasoconstrictor** in the traditional sense like ergotamines. Its primary action is through serotonin receptor agonism.
## **Clinical Pearl / High-Yield Fact**
A key point to remember about sumatriptan is that it is **contraindicated in patients with certain cardiovascular conditions**, such as coronary artery disease, cerebrovascular disease, or uncontrolled hypertension, due to its potential to cause vasoconstriction. Additionally, it should not be used within 24 hours of another triptan or ergotamine-containing or ergot-type drug.
## **Correct Answer:** D. serotonin receptor agonist